会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • BIOMARKERS FOR BREAST CANCER PREDICTION AND DIAGNOSIS
    • 乳腺癌预防和诊断的生物标志物
    • US20150292024A1
    • 2015-10-15
    • US14371083
    • 2012-01-09
    • Tao WangXiangyun QuFei Chen
    • Tao WangXiangyun QuFei Chen
    • C12Q1/68G01N33/574
    • C12Q1/6886C07K14/8139C12Q2600/156C12Q2600/158G01N33/57415G01N2333/8139
    • This invention provides the applications of CST1 gene and its splice variants (sequence shown in SEQ ID No.48) and cystatin SN protein coded by CST1 gene (sequence shown in SEQ ID No.52) for the predictions and diagnoses of human breast cancers. The invention can be used for the diagnosis of breast cancer and breast cancer metastasis, for the analysis for the susceptibility for breast cancer, for the evaluation of the treatments, medicine, efficacy and prognosis for original or metastatic breast cancer patients, and for the risk assessment for breast cancer or its metastasis. The methods described in this invention are of significant sensitivity, specificity and reliability. The invention provides the capturers of CST1 gene, its splice variants and cystatin SN and their applications in manufacturing diagnostic reagents, kits and chips for breast cancers. The diagnostic reagents, kits and chips for breast cancer are included in this invention.
    • 本发明提供CST1基因及其剪接变体(SEQ ID No.48所示序列)和CST1基因编码的半胱氨酸蛋白酶抑制蛋白SN蛋白(SEQ ID No.52所示序列)用于预测和诊断人乳腺癌的应用。 本发明可用于乳腺癌和乳腺癌转移的诊断,用于乳腺癌易感性分析,原发性或转移性乳腺癌患者的治疗,药物,功效和预后评估以及风险评估 评估乳腺癌或其转移。 本发明描述的方法具有显着的灵敏度,特异性和可靠性。 本发明提供CST1基因,其剪接变体和半胱氨酸蛋白酶抑制剂SN的捕获者及其在制造用于乳腺癌的诊断试剂,试剂盒和芯片中的应用。 用于乳腺癌的诊断试剂,试剂盒和芯片包括在本发明中。